Published in Neuroimage on September 01, 2002
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A (2003) 5.64
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol (2015) 3.58
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci (2009) 1.89
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage (2012) 1.71
Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci (2008) 1.64
Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging (2007) 1.58
Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage (2011) 1.54
Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biol Psychiatry (2014) 1.54
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49
Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry (2005) 1.45
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiol Aging (2010) 1.30
Neurodegenerative disease diagnosis using incomplete multi-modality data via matrix shrinkage and completion. Neuroimage (2014) 1.30
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am J Geriatr Psychiatry (2008) 1.24
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal (2013) 1.20
Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol (2010) 1.20
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. J Neurol (2012) 1.20
Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging (2010) 1.19
Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Psychiatry (2006) 1.19
Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage (2008) 1.18
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement (2014) 1.14
Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.14
Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT. Eur J Nucl Med Mol Imaging (2004) 1.11
Stability Of Default-Mode Network Activity In The Aging Brain. Brain Imaging Behav (2009) 1.11
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging (2013) 1.07
Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease. J Neurol (2007) 1.07
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement (2008) 1.05
Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls. J Cereb Blood Flow Metab (2010) 1.03
Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur J Nucl Med Mol Imaging (2005) 1.03
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin (2013) 1.02
Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med (2012) 1.02
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. Neuroimage (2012) 1.00
Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 0.99
Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS One (2012) 0.98
Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging (2005) 0.97
Brain imaging in the study of Alzheimer's disease. Neuroimage (2011) 0.97
Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol (2005) 0.97
Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology (2011) 0.97
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging Behav (2012) 0.96
Altered connectivity pattern of hubs in default-mode network with Alzheimer's disease: an Granger causality modeling approach. PLoS One (2011) 0.96
Fronto-striatal deficit in Parkinson's disease during semantic event sequencing. Neurobiol Aging (2006) 0.96
Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC Neurol (2009) 0.95
PET-based molecular imaging in neuroscience. Eur J Nucl Med Mol Imaging (2003) 0.95
Memory loss in Alzheimer's disease. Dialogues Clin Neurosci (2013) 0.94
The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. IEEE/ACM Trans Comput Biol Bioinform (2013) 0.94
Regional cerebral metabolic patterns demonstrate the role of anterior forebrain mesocircuit dysfunction in the severely injured brain. Proc Natl Acad Sci U S A (2014) 0.94
Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. Eur J Nucl Med Mol Imaging (2009) 0.94
Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment. PLoS One (2013) 0.93
Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93
Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. J Alzheimers Dis (2015) 0.93
Anatomical brain images alone can accurately diagnose chronic neuropsychiatric illnesses. PLoS One (2012) 0.93
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry (2003) 0.93
Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI. Magn Reson Imaging (2011) 0.92
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging (2014) 0.92
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. Neuroimage Clin (2014) 0.91
Combining PET images and neuropsychological test data for automatic diagnosis of Alzheimer's disease. PLoS One (2014) 0.91
Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. Neurol Sci (2011) 0.90
Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease. J Neurol (2007) 0.90
State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications. Neuroradiology (2015) 0.90
What have novel imaging techniques revealed about metabolism in the aging brain? Future Neurol (2014) 0.89
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin (2014) 0.89
Functional neuroanatomy of auditory scene analysis in Alzheimer's disease. Neuroimage Clin (2015) 0.89
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 0.89
Neural basis for recognition confidence in younger and older adults. Psychol Aging (2009) 0.89
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology (2015) 0.88
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP. Eur J Nucl Med Mol Imaging (2006) 0.87
Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. Eur J Nucl Med Mol Imaging (2007) 0.87
Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J Neurosci (2014) 0.87
The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment. J Neurol (2010) 0.87
Functional alteration patterns of default mode networks: comparisons of normal aging, amnestic mild cognitive impairment and Alzheimer's disease. Eur J Neurosci (2013) 0.86
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimers Dement (2013) 0.86
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging (2011) 0.86
Synapse stability in the precuneus early in the progression of Alzheimer's disease. J Alzheimers Dis (2013) 0.85
A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int (2014) 0.85
Female advantage in verbal memory: Evidence of sex-specific cognitive reserve. Neurology (2016) 0.85
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med (2012) 0.85
Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders. J Child Psychol Psychiatry (2012) 0.85
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging (2015) 0.85
Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study. PLoS One (2013) 0.84
White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease. PLoS One (2013) 0.84
Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. PLoS One (2013) 0.84
Using biomarkers to improve detection of Alzheimer's disease. Neurodegener Dis Manag (2011) 0.84
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clin (2014) 0.84
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer-membrane proteins? Cell (1981) 8.24
In vitro hemolytic characteristic of Vibrio parahaemolyticus: its close correlation with human pathogenicity. J Bacteriol (1969) 8.04
The rate of loss of weight in skeletal muscle after nerve section with some observations on the effect of stimulation and other treatment. J Physiol (1915) 6.49
Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol (1999) 5.84
Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light. Mol Gen Genet (1977) 5.61
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs (1996) 5.45
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care (1999) 5.37
Studies on the enteropathogenic, facultatively halophilic bacterium, Vibrio parahaemolyticus. 3. Enteropathogenicity. Jpn J Med Sci Biol (1968) 5.35
Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry (1982) 5.33
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
A cyclin B homolog in S. cerevisiae: chronic activation of the Cdc28 protein kinase by cyclin prevents exit from mitosis. Cell (1991) 4.90
The T-region of Ti plasmids codes for an enzyme synthesizing indole-3-acetic acid. Eur J Biochem (1984) 4.88
Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77
Universal spelling. Nature (1996) 4.59
Transient regulation of protein synthesis in Escherichia coli upon shift-up of growth temperature. J Bacteriol (1978) 4.38
The physiological action of physostigmine and its action on denervated skeletal muscle. J Physiol (1915) 4.37
Synthesis and assembly of the membrane proteins in E. coli. Cell (1977) 4.18
Dyslexia: cultural diversity and biological unity. Science (2001) 4.17
RecA protein-dependent cleavage of UmuD protein and SOS mutagenesis. Proc Natl Acad Sci U S A (1988) 4.12
A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett (1967) 4.11
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
Arabidopsis NPL1: a phototropin homolog controlling the chloroplast high-light avoidance response. Science (2001) 3.93
Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage (2001) 3.87
Cyclin-B homologs in Saccharomyces cerevisiae function in S phase and in G2. Genes Dev (1992) 3.83
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology (2003) 3.60
Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain (1990) 3.54
Concomitant induction of phenylalanine ammonia-lyase and flavanone synthase mRNAs in irradiated plant cells. J Biol Chem (1979) 3.38
SecA protein hydrolyzes ATP and is an essential component of the protein translocation ATPase of Escherichia coli. EMBO J (1989) 3.33
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage (2005) 3.28
A temperature-sensitive mutant of E. coli exhibiting slow processing of exported proteins. Cell (1983) 3.26
Topology analysis of the SecY protein, an integral membrane protein involved in protein export in Escherichia coli. EMBO J (1987) 3.24
Corneal neovascularization. Curr Opin Ophthalmol (2001) 3.22
Regional differences in semen quality in Europe. Hum Reprod (2001) 3.19
Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18
Biosynthesis of RNA polymerase in Escherichia coli. I. Control of RNA polymerase content at various growth rates. Mol Gen Genet (1974) 3.15
Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem (1996) 3.10
Synthesis, assembly into the cytoplasmic membrane, and proteolytic processing of the precursor of coliphage M13 coat protein. J Biol Chem (1980) 3.09
Determination of the ID50 values of antibacterial agents in agar. J Antibiot (Tokyo) (1978) 3.08
Identification and characterization of an Escherichia coli gene required for the formation of correctly folded alkaline phosphatase, a periplasmic enzyme. EMBO J (1992) 3.08
Base-change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics (1970) 3.05
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat Struct Biol (2001) 3.00
Diaschisis. Stroke (1986) 2.94
An in vitro investigation of the acetabular labral seal in hip joint mechanics. J Biomech (2003) 2.92
Heat shock regulatory gene (htpR) of Escherichia coli is required for growth at high temperature but is dispensable at low temperature. Proc Natl Acad Sci U S A (1984) 2.89
Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells. Nature (1988) 2.89
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol (1997) 2.89
The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr (1994) 2.88
Identification by positron emission tomography of neuronal loss in acute vegetative state. Lancet (2000) 2.85
Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp Brain Res (1996) 2.80
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
Brain activity during observation of actions. Influence of action content and subject's strategy. Brain (1997) 2.73
A cultural effect on brain function. Nat Neurosci (2000) 2.69
The acetabular labrum seal: a poroelastic finite element model. Clin Biomech (Bristol, Avon) (2000) 2.64
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62
The influence of the acetabular labrum on hip joint cartilage consolidation: a poroelastic finite element model. J Biomech (2000) 2.62
Hyperammonaemia and Helicobacter pylori. Lancet (1995) 2.59
Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol (1996) 2.54
Effects of mutations in heat-shock genes groES and groEL on protein export in Escherichia coli. EMBO J (1989) 2.53
De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology (2009) 2.53
ARR1, a transcription factor for genes immediately responsive to cytokinins. Science (2001) 2.50
Protein, lipid and water organization in bacteriorhodopsin crystals: a molecular view of the purple membrane at 1.9 A resolution. Structure (1999) 2.50
Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut (2001) 2.49
The Sec protein-translocation pathway. Trends Microbiol (2001) 2.48
Linkage disequilibrium in natural populations of Drosophila melanogaster Seasonal variation. Genetics (1977) 2.47
Respiratory hospital admissions and summertime haze air pollution in Toronto, Ontario: consideration of the role of acid aerosols. Environ Res (1994) 2.47
High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut (1999) 2.46
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1979) 2.45
Genetic evidence that the endodermis is essential for shoot gravitropism in Arabidopsis thaliana. Plant J (1998) 2.41
Pericentric inversions of human chromosomes 9 and 10. Am J Hum Genet (1974) 2.40
Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke (1982) 2.40
Spectrodensitometric determination of trichothecene mycotoxins with 4-(p-nitrobenzyl)pyridine on silica gel thin-layer chromatograms. J Chromatogr (1979) 2.38
Genetic and molecular characteristics of X-ray-sensitive mutants of Escherichia coli defective in repair synthesis. J Bacteriol (1970) 2.37
Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J (2005) 2.37
The anatomy of unilateral neglect after right-hemisphere stroke lesions. A clinical/CT-scan correlation study in man. Neuropsychologia (1986) 2.35
Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care (1995) 2.33
The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33
Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1987) 2.33
A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A (2000) 2.31
Respiratory chain is required to maintain oxidized states of the DsbA-DsbB disulfide bond formation system in aerobically growing Escherichia coli cells. Proc Natl Acad Sci U S A (1997) 2.31
Structural analysis of the umu operon required for inducible mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.30
Epidemiological studies of acute ozone exposures and mortality. J Expo Anal Environ Epidemiol (2001) 2.30
Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature (1991) 2.28
Isolation and physical mapping of temperature-sensitive mutants defective in heat-shock induction of proteins in Escherichia coli. Mol Gen Genet (1984) 2.27
Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol (2001) 2.27
STN-DBS activates the target area in Parkinson disease: an FDG-PET study. Neurology (2008) 2.27